img

Global and India Head and Neck Cancer (HNC) Therapeutic Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Software

Publisher : MRA | Format : PDF

Global and India Head and Neck Cancer (HNC) Therapeutic Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Head and Neck Cancer (HNC) Therapeutic Market
This report focuses on global and India Head and Neck Cancer (HNC) Therapeutic market, also covers the segmentation data of other regions in regional level and county level.
The global Head and Neck Cancer (HNC) Therapeutic revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India the Head and Neck Cancer (HNC) Therapeutic revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Head and Neck Cancer (HNC) Therapeutic include Eli Lilly, Sanofi, Merck & Co., Clinigen Group, Bristol-Myers Squibb, AstraZeneca, Takeda Pharmaceutical, Teva Pharmaceutical Industries and Hoffmann-La Roche, etc. The global five biggest players hold a share of % in 2023.
Global Head and Neck Cancer (HNC) Therapeutic Scope and Market Size
Head and Neck Cancer (HNC) Therapeutic market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Head and Neck Cancer (HNC) Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Head and Neck Cancer (HNC) Therapeutic market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.



By Company


Eli Lilly
Sanofi
Merck & Co.
Clinigen Group
Bristol-Myers Squibb
AstraZeneca
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Hoffmann-La Roche
Coherus BioSciences
Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy

Segment by Application


Hospitals
Clinics
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Head and Neck Cancer (HNC) Therapeutic definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Head and Neck Cancer (HNC) Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Head and Neck Cancer (HNC) Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Head and Neck Cancer (HNC) Therapeutic revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Head and Neck Cancer (HNC) Therapeutic Product Introduction
1.2 Global Head and Neck Cancer (HNC) Therapeutic Outlook 2018 VS 2023 VS 2033
1.2.1 Global Head and Neck Cancer (HNC) Therapeutic Market Size for the Year 2018-2033
1.2.2 India Head and Neck Cancer (HNC) Therapeutic Market Size for the Year 2018-2033
1.3 Head and Neck Cancer (HNC) Therapeutic Market Size, India VS Global, 2018 VS 2023 VS 2033
1.3.1 The Market Share of India Head and Neck Cancer (HNC) Therapeutic in Global, 2018 VS 2023 VS 2033
1.3.2 The Growth Rate of Head and Neck Cancer (HNC) Therapeutic Market Size, India VS Global, 2018 VS 2023 VS 2033
1.4 Head and Neck Cancer (HNC) Therapeutic Market Dynamics
1.4.1 Head and Neck Cancer (HNC) Therapeutic Industry Trends
1.4.2 Head and Neck Cancer (HNC) Therapeutic Market Drivers
1.4.3 Head and Neck Cancer (HNC) Therapeutic Market Challenges
1.4.4 Head and Neck Cancer (HNC) Therapeutic Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Head and Neck Cancer (HNC) Therapeutic by Type
2.1 Head and Neck Cancer (HNC) Therapeutic Market Segment by Type
2.1.1 Chemotherapy
2.1.2 Immunotherapy
2.1.3 Targeted Therapy
2.2 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018, 2023 & 2033)
2.3 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2033)
2.4 India Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018, 2023 & 2033)
2.5 India Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2033)
3 Head and Neck Cancer (HNC) Therapeutic by Application
3.1 Head and Neck Cancer (HNC) Therapeutic Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018, 2023 & 2033)
3.3 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2033)
3.4 India Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018, 2023 & 2033)
3.5 India Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2033)
4 Global Head and Neck Cancer (HNC) Therapeutic Competitor Landscape by Company
4.1 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Company
4.1.1 Global Key Companies of Head and Neck Cancer (HNC) Therapeutic, Ranked by Revenue (2023)
4.1.2 Global Head and Neck Cancer (HNC) Therapeutic Revenue by Player (2018-2023)
4.2 Global Head and Neck Cancer (HNC) Therapeutic Concentration Ratio (CR)
4.2.1 Head and Neck Cancer (HNC) Therapeutic Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Head and Neck Cancer (HNC) Therapeutic in 2023
4.2.3 Global Head and Neck Cancer (HNC) Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Head and Neck Cancer (HNC) Therapeutic Head office and Area Served
4.4 Global Key Players of Head and Neck Cancer (HNC) Therapeutic, Product and Application
4.5 Global Key Players of Head and Neck Cancer (HNC) Therapeutic, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Head and Neck Cancer (HNC) Therapeutic Market Size by Company
4.7.1 Key Players of Head and Neck Cancer (HNC) Therapeutic in India, Ranked by Revenue (2023)
4.7.2 India Head and Neck Cancer (HNC) Therapeutic Revenue by Players (2021, 2023 & 2023)
5 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Region
5.1 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Region: 2018 VS 2023 VS 2033
5.2 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Region (2018-2033)
5.2.1 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Region: 2018-2023
5.2.2 Global Head and Neck Cancer (HNC) Therapeutic Market Size by Region (2024-2033)
6 Americas
6.1 Americas Head and Neck Cancer (HNC) Therapeutic Market Size YoY Growth 2018-2033
6.2 Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Type
6.2.1 Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2023)
6.2.2 Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2024-2033)
6.2.3 Americas Head and Neck Cancer (HNC) Therapeutic Market Share by Type (2018-2033)
6.3 Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Application
6.3.1 Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2023)
6.3.2 Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2024-2033)
6.3.3 Americas Head and Neck Cancer (HNC) Therapeutic Market Share by Application (2018-2033)
6.4 Americas Head and Neck Cancer (HNC) Therapeutic Market Facts & Figures by Country (2018, 2023 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Head and Neck Cancer (HNC) Therapeutic Market Size YoY Growth 2018-2033
7.2 EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Type
7.2.1 EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2023)
7.2.2 EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2024-2033)
7.2.3 EMEA Head and Neck Cancer (HNC) Therapeutic Market Share by Type (2018-2033)
7.3 EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Application
7.3.1 EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2023)
7.3.2 EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2024-2033)
7.3.3 EMEA Head and Neck Cancer (HNC) Therapeutic Market Share by Application (2018-2033)
7.4 EMEA Head and Neck Cancer (HNC) Therapeutic Market Facts & Figures by Country (2018, 2023 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Head and Neck Cancer (HNC) Therapeutic Market Size YoY Growth 2018-2033
8.2 China Head and Neck Cancer (HNC) Therapeutic Market Size by Type
8.2.1 China Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2023)
8.2.2 China Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2024-2033)
8.2.3 China Head and Neck Cancer (HNC) Therapeutic Market Share by Type (2018-2033)
8.3 China Head and Neck Cancer (HNC) Therapeutic Market Size by Application
8.3.1 China Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2023)
8.3.2 China Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2024-2033)
8.3.3 China Head and Neck Cancer (HNC) Therapeutic Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Head and Neck Cancer (HNC) Therapeutic Market Size YoY Growth 2018-2033
9.2 APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Type
9.2.1 APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2023)
9.2.2 APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2024-2033)
9.2.3 APAC Head and Neck Cancer (HNC) Therapeutic Market Share by Type (2018-2033)
9.3 APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Application
9.3.1 APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2023)
9.3.2 APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2024-2033)
9.3.3 APAC Head and Neck Cancer (HNC) Therapeutic Market Share by Application (2018-2033)
9.4 APAC Head and Neck Cancer (HNC) Therapeutic Market Facts & Figures by Country (2018, 2023 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Details
10.1.2 Eli Lilly Business Overview
10.1.3 Eli Lilly Head and Neck Cancer (HNC) Therapeutic Introduction
10.1.4 Eli Lilly Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
10.1.5 Eli Lilly Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Details
10.2.2 Sanofi Business Overview
10.2.3 Sanofi Head and Neck Cancer (HNC) Therapeutic Introduction
10.2.4 Sanofi Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
10.2.5 Sanofi Recent Development
10.3 Merck & Co.
10.3.1 Merck & Co. Company Details
10.3.2 Merck & Co. Business Overview
10.3.3 Merck & Co. Head and Neck Cancer (HNC) Therapeutic Introduction
10.3.4 Merck & Co. Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
10.3.5 Merck & Co. Recent Development
10.4 Clinigen Group
10.4.1 Clinigen Group Company Details
10.4.2 Clinigen Group Business Overview
10.4.3 Clinigen Group Head and Neck Cancer (HNC) Therapeutic Introduction
10.4.4 Clinigen Group Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
10.4.5 Clinigen Group Recent Development
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Company Details
10.5.2 Bristol-Myers Squibb Business Overview
10.5.3 Bristol-Myers Squibb Head and Neck Cancer (HNC) Therapeutic Introduction
10.5.4 Bristol-Myers Squibb Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
10.5.5 Bristol-Myers Squibb Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Details
10.6.2 AstraZeneca Business Overview
10.6.3 AstraZeneca Head and Neck Cancer (HNC) Therapeutic Introduction
10.6.4 AstraZeneca Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
10.6.5 AstraZeneca Recent Development
10.7 Takeda Pharmaceutical
10.7.1 Takeda Pharmaceutical Company Details
10.7.2 Takeda Pharmaceutical Business Overview
10.7.3 Takeda Pharmaceutical Head and Neck Cancer (HNC) Therapeutic Introduction
10.7.4 Takeda Pharmaceutical Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
10.7.5 Takeda Pharmaceutical Recent Development
10.8 Teva Pharmaceutical Industries
10.8.1 Teva Pharmaceutical Industries Company Details
10.8.2 Teva Pharmaceutical Industries Business Overview
10.8.3 Teva Pharmaceutical Industries Head and Neck Cancer (HNC) Therapeutic Introduction
10.8.4 Teva Pharmaceutical Industries Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
10.8.5 Teva Pharmaceutical Industries Recent Development
10.9 Hoffmann-La Roche
10.9.1 Hoffmann-La Roche Company Details
10.9.2 Hoffmann-La Roche Business Overview
10.9.3 Hoffmann-La Roche Head and Neck Cancer (HNC) Therapeutic Introduction
10.9.4 Hoffmann-La Roche Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
10.9.5 Hoffmann-La Roche Recent Development
10.10 Coherus BioSciences
10.10.1 Coherus BioSciences Company Details
10.10.2 Coherus BioSciences Business Overview
10.10.3 Coherus BioSciences Head and Neck Cancer (HNC) Therapeutic Introduction
10.10.4 Coherus BioSciences Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
10.10.5 Coherus BioSciences Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Head and Neck Cancer (HNC) Therapeutic Market Size India VS Global, CAGR (2018 VS 2023 VS 2033)
Table 2. Head and Neck Cancer (HNC) Therapeutic Market Trends
Table 3. Head and Neck Cancer (HNC) Therapeutic Market Drivers
Table 4. Head and Neck Cancer (HNC) Therapeutic Market Challenges
Table 5. Head and Neck Cancer (HNC) Therapeutic Market Restraints
Table 6. Global Head and Neck Cancer (HNC) Therapeutic Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 7. India Head and Neck Cancer (HNC) Therapeutic Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 8. Global Head and Neck Cancer (HNC) Therapeutic Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 9. India Head and Neck Cancer (HNC) Therapeutic Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 10. Global Key Companies of Head and Neck Cancer (HNC) Therapeutic, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Head and Neck Cancer (HNC) Therapeutic Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Head and Neck Cancer (HNC) Therapeutic Revenue Share by Player, 2018-2023
Table 13. Global Head and Neck Cancer (HNC) Therapeutic Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Head and Neck Cancer (HNC) Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Head and Neck Cancer (HNC) Therapeutic as of 2023)
Table 15. Global Key Players of Head and Neck Cancer (HNC) Therapeutic, Headquarters and Area Served
Table 16. Global Key Players of Head and Neck Cancer (HNC) Therapeutic, Product and Application
Table 17. Global Key Players of Head and Neck Cancer (HNC) Therapeutic, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Head and Neck Cancer (HNC) Therapeutic in India, Ranked by Revenue (2023) & (US$ Million)
Table 20. India Head and Neck Cancer (HNC) Therapeutic Revenue by Players, (US$ Million), 2021, 2023 & 2023
Table 21. India Head and Neck Cancer (HNC) Therapeutic Revenue Share by Players, 2021, 2023 & 2023
Table 22. Global Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 23. Global Head and Neck Cancer (HNC) Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Head and Neck Cancer (HNC) Therapeutic Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 30. Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Head and Neck Cancer (HNC) Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 49. APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Head and Neck Cancer (HNC) Therapeutic Market Size by Region (2024-2033) & (US$ Million)
Table 51. Eli Lilly Company Details
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Head and Neck Cancer (HNC) Therapeutic Product
Table 54. Eli Lilly Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023) & (US$ Million)
Table 55. Eli Lilly Recent Development
Table 56. Sanofi Company Details
Table 57. Sanofi Business Overview
Table 58. Sanofi Head and Neck Cancer (HNC) Therapeutic Product
Table 59. Sanofi Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Merck & Co. Company Details
Table 62. Merck & Co. Business Overview
Table 63. Merck & Co. Head and Neck Cancer (HNC) Therapeutic Product
Table 64. Merck & Co. Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023) & (US$ Million)
Table 65. Merck & Co. Recent Development
Table 66. Clinigen Group Company Details
Table 67. Clinigen Group Business Overview
Table 68. Clinigen Group Head and Neck Cancer (HNC) Therapeutic Product
Table 69. Clinigen Group Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023) & (US$ Million)
Table 70. Clinigen Group Recent Development
Table 71. Bristol-Myers Squibb Company Details
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Head and Neck Cancer (HNC) Therapeutic Product
Table 74. Bristol-Myers Squibb Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023) & (US$ Million)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Head and Neck Cancer (HNC) Therapeutic Product
Table 79. AstraZeneca Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Takeda Pharmaceutical Company Details
Table 82. Takeda Pharmaceutical Business Overview
Table 83. Takeda Pharmaceutical Head and Neck Cancer (HNC) Therapeutic Product
Table 84. Takeda Pharmaceutical Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023) & (US$ Million)
Table 85. Takeda Pharmaceutical Recent Development
Table 86. Teva Pharmaceutical Industries Company Details
Table 87. Teva Pharmaceutical Industries Business Overview
Table 88. Teva Pharmaceutical Industries Head and Neck Cancer (HNC) Therapeutic Product
Table 89. Teva Pharmaceutical Industries Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023) & (US$ Million)
Table 90. Teva Pharmaceutical Industries Recent Development
Table 91. Hoffmann-La Roche Company Details
Table 92. Hoffmann-La Roche Business Overview
Table 93. Hoffmann-La Roche Head and Neck Cancer (HNC) Therapeutic Product
Table 94. Hoffmann-La Roche Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023) & (US$ Million)
Table 95. Hoffmann-La Roche Recent Development
Table 96. Coherus BioSciences Company Details
Table 97. Coherus BioSciences Business Overview
Table 98. Coherus BioSciences Head and Neck Cancer (HNC) Therapeutic Product
Table 99. Coherus BioSciences Revenue in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023) & (US$ Million)
Table 100. Coherus BioSciences Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Head and Neck Cancer (HNC) Therapeutic Product Picture
Figure 2. Global Head and Neck Cancer (HNC) Therapeutic Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Head and Neck Cancer (HNC) Therapeutic Market Size 2018-2033 (US$ Million)
Figure 4. India Head and Neck Cancer (HNC) Therapeutic Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 5. India Head and Neck Cancer (HNC) Therapeutic Market Size 2018-2033 (US$ Million)
Figure 6. India Head and Neck Cancer (HNC) Therapeutic Market Share in Global 2018-2033
Figure 7. Head and Neck Cancer (HNC) Therapeutic Report Years Considered
Figure 8. Product Picture of Chemotherapy
Figure 9. Product Picture of Immunotherapy
Figure 10. Product Picture of Targeted Therapy
Figure 11. Global Head and Neck Cancer (HNC) Therapeutic Market Share by Type in 2023 & 2033
Figure 12. Global Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2033) & (US$ Million)
Figure 13. Global Head and Neck Cancer (HNC) Therapeutic Market Share by Type (2018-2033)
Figure 14. India Head and Neck Cancer (HNC) Therapeutic Market Share by Type in 2023 & 2033
Figure 15. India Head and Neck Cancer (HNC) Therapeutic Market Size by Type (2018-2033) & (US$ Million)
Figure 16. India Head and Neck Cancer (HNC) Therapeutic Market Share by Type (2018-2033)
Figure 17. Product Picture of Hospitals
Figure 18. Product Picture of Clinics
Figure 19. Product Picture of Others
Figure 20. Global Head and Neck Cancer (HNC) Therapeutic Market Share by Application in 2023 & 2033
Figure 21. Global Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2033) & (US$ Million)
Figure 22. Global Head and Neck Cancer (HNC) Therapeutic Market Share by Application (2018-2033)
Figure 23. India Head and Neck Cancer (HNC) Therapeutic Market Share by Application in 2023 & 2033
Figure 24. India Head and Neck Cancer (HNC) Therapeutic Market Size by Application (2018-2033) & (US$ Million)
Figure 25. India Head and Neck Cancer (HNC) Therapeutic Market Share by Application (2018-2033)
Figure 26. The Top 5 and 10 Largest Companies of Head and Neck Cancer (HNC) Therapeutic in the World: Market Share by Head and Neck Cancer (HNC) Therapeutic Revenue in 2023
Figure 27. Global Head and Neck Cancer (HNC) Therapeutic Market Size Market Share by Region: 2018 VS 2023 VS 2033
Figure 28. Global Head and Neck Cancer (HNC) Therapeutic Market Share by Region (2018-2033)
Figure 29. Americas Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate 2018-2033 (US$ Million)
Figure 30. Americas Head and Neck Cancer (HNC) Therapeutic Market Share by Type (2018-2033)
Figure 31. Americas Head and Neck Cancer (HNC) Therapeutic Market Share by Application (2018-2033)
Figure 32. United States Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Canada Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Mexico Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Brazil Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. EMEA Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate 2018-2033 (US$ Million)
Figure 37. EMEA Head and Neck Cancer (HNC) Therapeutic Market Share by Type (2018-2033)
Figure 38. EMEA Head and Neck Cancer (HNC) Therapeutic Market Share by Application (2018-2033)
Figure 39. Europe Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Middle East Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Africa Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. China Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate 2018-2033 (US$ Million)
Figure 43. China Head and Neck Cancer (HNC) Therapeutic Market Share by Type (2018-2033)
Figure 44. China Head and Neck Cancer (HNC) Therapeutic Market Share by Application (2018-2033)
Figure 45. APAC Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate 2018-2033 (US$ Million)
Figure 46. APAC Head and Neck Cancer (HNC) Therapeutic Market Share by Type (2018-2033)
Figure 47. APAC Head and Neck Cancer (HNC) Therapeutic Market Share by Application (2018-2033)
Figure 48. Japan Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. South Korea Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. China Taiwan Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. Southeast Asia Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. India Head and Neck Cancer (HNC) Therapeutic Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. Eli Lilly Revenue Growth Rate in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
Figure 54. Sanofi Revenue Growth Rate in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
Figure 55. Merck & Co. Revenue Growth Rate in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
Figure 56. Clinigen Group Revenue Growth Rate in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
Figure 58. AstraZeneca Revenue Growth Rate in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
Figure 59. Takeda Pharmaceutical Revenue Growth Rate in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
Figure 60. Teva Pharmaceutical Industries Revenue Growth Rate in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
Figure 61. Hoffmann-La Roche Revenue Growth Rate in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
Figure 62. Coherus BioSciences Revenue Growth Rate in Head and Neck Cancer (HNC) Therapeutic Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed